The Future of Cancer Care

Linconln

Research is is at the Core

“We’re focused on targeted therapies, but there is an opportunity to provide concurrent immunotherapy. We feel the combination of this will be much more effective, versus treating separately. This is something we’re researching now.” Bryce Moulton, Intermountain Precision Genomics


See full video here: 



The Future of Cancer Care is Bright

“The future of cancer care is really bright. It is full of new targeted drugs, immunotherapy, and we see the potential of making cancer a chronic disease, not an end.” – Dr. Derrick Haslem, Intermountain Precision Genomics

See full video here:


Precision Medicine is Improving Outcomes

“Liquid biopsies will be a great benefit to patients by testing by blood versus the standard tissue process. There is also mounting evidence targeted therapies are helping patients. Prescribing patients based on genomics is working, and that is very exciting. We will see better understanding of when to implement precision medicine and even find better outcomes by treating patients sooner.”  - Dr. Lincoln Nadauld, Intermountain Precision Genomics

See the full video here: https://www.youtube.com/watch?v=RYq0Qtv_RgY